MEASUREMENT OF HPRT MUTANT FREQUENCIES IN LYMPHOCYTE-T FROM HEALTHY-HUMAN POPULATIONS

被引:73
作者
BRANDA, RF
SULLIVAN, LM
ONEILL, JP
FALTA, MT
NICKLAS, JA
HIRSCH, B
VACEK, PM
ALBERTINI, RJ
机构
[1] UNIV VERMONT,DEPT MED STAT,BURLINGTON,VT 05401
[2] UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
来源
MUTATION RESEARCH | 1993年 / 285卷 / 02期
关键词
HPRT; 6-THIOGUANINE-RESISTANT; T-LYMPHOCYTES; HUMAN POPULATION MONITORING;
D O I
10.1016/0027-5107(93)90115-V
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Somatic cell mutant frequencies at the hprt locus of the X-chromosome were measured with the T-lymphocyte cloning technique in healthy human populations. A statistical analysis was performed of assays from 232 individuals (77 males and 155 females) ranging in age from 19 to 80 years. Data from 4 donor groups were compiled: (a) 132 participants in a study of identical and fraternal twins; (b) 17 health care workers studied as part of an assessment of the risks of handling chemotherapeutic drugs; (c) 62 women with benign breast masses; and (d) 21 normal laboratory and office personnel. The relationship between age and mutant frequency (MF) was expressed by the equation: In MF = 1.46 + 0.018 age (P < 0.001). Thus, MF increased by about 2% per year. Increases in cloning efficiency (CE) reduced the MF, as shown in the equation: In MF = 2.91-1.32 CE (P < 0.001). CE was significantly related to age (CE = 0.47-0.002 age, P = 0.038), and the interdependent relationship between MF, age and CE expressed by the equation: In MF = 1.99-1.13 CE + 0.016 age was significant at the P < 0.001 level. There was no statistically significant effect of donor gender or smoking history on MF in our population, but CE was significantly lower in males (P < 0.001). These findings confirm the importance of age and CE as factors which influence the thioguanine-resistant MF in circulating T-lymphocytes from normal adults.
引用
收藏
页码:267 / 279
页数:13
相关论文
共 28 条
[21]   REFINEMENT OF A LYMPHOCYTE-T CLONING ASSAY TO QUANTIFY THE INVIVO THIOGUANINE-RESISTANT MUTANT FREQUENCY IN HUMANS [J].
ONEILL, JP ;
MCGINNISS, MJ ;
BERMAN, JK ;
SULLIVAN, LM ;
NICKLAS, JA ;
ALBERTINI, RJ .
MUTAGENESIS, 1987, 2 (02) :87-94
[22]   GENOTOXIC EFFECTS OF RADIOTHERAPY AND CHEMOTHERAPY ON THE CIRCULATING LYMPHOCYTES OF BREAST-CANCER PATIENTS .3. MEASUREMENT OF MUTANT FREQUENCY TO 6-THIOGUANINE RESISTANCE [J].
SALATREPAT, M ;
COLE, J ;
GREEN, MHL ;
RIGAUD, O ;
VILCOQ, JR ;
MOUSTACCHI, E .
MUTAGENESIS, 1990, 5 (06) :593-598
[23]   EXPOSURE OF NUCLEAR-MEDICINE PATIENTS TO IONIZING-RADIATION IS ASSOCIATED WITH RISES IN HPRT- MUTANT FREQUENCY IN PERIPHERAL LYMPHOCYTES-T [J].
SEIFERT, AM ;
BRADLEY, WEC ;
MESSING, K .
MUTATION RESEARCH, 1987, 191 (01) :57-63
[24]   ENUMERATION OF 6-THIOGUANINE-RESISTANT PERIPHERAL-BLOOD LYMPHOCYTES IN MAN AS A POTENTIAL TEST FOR SOMATIC-CELL MUTATIONS ARISING INVIVO [J].
STRAUSS, GH ;
ALBERTINI, RJ .
MUTATION RESEARCH, 1979, 61 (02) :353-379
[25]  
STRAUSS GH, 1977, PROGR GENETIC TOXICO, V2, P327
[26]   DETECTION OF SOMATIC MUTANTS IN MAN - HPRT MUTATIONS IN LYMPHOCYTES AND HEMOGLOBIN MUTATIONS IN ERYTHROCYTES [J].
TATES, AD ;
BERNINI, LF ;
NATARAJAN, AT ;
PLOEM, JS ;
VERWOERD, NP ;
COLE, J ;
GREEN, MHL ;
ARLETT, CF ;
NORRIS, PN .
MUTATION RESEARCH, 1989, 213 (01) :73-82
[27]   USE OF THE CLONAL ASSAY FOR THE MEASUREMENT OF FREQUENCIES OF HPRT MUTANTS IN LYMPHOCYTES-T FROM 5 CONTROL POPULATIONS [J].
TATES, AD ;
VANDAM, FJ ;
VANMOSSEL, H ;
SCHOEMAKER, H ;
THIJSSEN, JCP ;
WOLDRING, VM ;
ZWINDERMAN, AH ;
NATARAJAN, AT .
MUTATION RESEARCH, 1991, 253 (02) :199-213
[28]  
VIJAYALAXMI EHJ, 1984, MUTAT RES, V125, P87